Market Research Logo

Global Pharmacogenomics (PGx) Market Analysis & Trends - Technology (Polymerase Chain Reaction (PCR), Microarray and Sequencing), Therapeutic Applications (Cardiovascular Diseases (CVD), Central Nervous System (CNS), Cancer/Oncology and Infectious Disease

Global Pharmacogenomics (PGx) Market Analysis & Trends - Technology (Polymerase Chain Reaction (PCR), Microarray and Sequencing), Therapeutic Applications (Cardiovascular Diseases (CVD), Central Nervous System (CNS), Cancer/Oncology and Infectious Diseases) - Forecast to 2025

The Global Pharmacogenomics (PGx) Market is poised to grow at a CAGR of around XX% over the next decade to reach approximately $XX million by 2025. Some of the prominent trends that the market is witnessing include advancements and innovations in new healthcare technologies, rapidly growing demand in emerging regions, emergence of pharmacogenetics heralds and Growth Opportunities/Investment Opportunities

Depending on the ecosystem players the market is segmented by service providers, pharmaceuticals companies and diagnostic test companies.

By technology the market is divided into Polymerase Chain Reaction (PCR), microarray, sequencing and other technologies. Sequencing segment is further segmented into pyrosequencing, Next-Generation Sequencing (NGS) and Sanger sequencing. Other technologies are further classified into electrophoresis and mass spectrometry.

Based on therapeutic applications the market is categorized into Cardiovascular Diseases (CVD), Central Nervous System (CNS), cancer/oncology, infectious diseases and other diseases.

This industry report analyzes the global markets for Pharmacogenomics (PGx) across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

The Pharmacogenomics (PGx) Market report provides data tables, includes charts and graphs for visual analysis.

Regional Analysis:
North America
US
Canada
Mexico

Europe
France
Germany
Italy
Spain
UK
Rest of Europe

Asia Pacific
China
Japan
India
Australia
New Zealand
Rest of Asia

Middle East
Saudi Arabia
UAE
Rest of Middle East

Latin America
Argentina
Brazil
Rest of Latin America

Rest of the World
Africa
Caribbean

Report Highlights:
The report provides a detailed analysis on current and future market trends to identify the investment opportunities
Market forecasts till 2025, using estimated market values as the base numbers
Key market trends across the business segments, Regions and Countries
Key developments and strategies observed in the market
Market Dynamics such as Drivers, Restraints, Opportunities and other trends
In-depth company profiles of key players and upcoming prominent players
Growth prospects among the emerging nations through 2025
Market opportunities and recommendations for new investments


1 Market Outline
1.1 Research Methodology
1.1.1 Research Approach & Sources
1.2 Market Trends
1.3 Regulatory Factors
1.4 Technology Analysis
1.5 Application Analysis
1.6 Strategic Benchmarking
1.7 Opportunity Analysis
2 Executive Summary
3 Market Overview
3.1 Current Trends
3.1.1 Advancements and innovations in new healthcare technologies
3.1.2 Rapidly growing demand in emerging regions
3.1.3 Emergence of pharmacogenetics heralds
3.1.4 Growth Opportunities/Investment Opportunities
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness
3.4.1 Bargaining power of suppliers
3.4.2 Bargaining power of buyers
3.4.3 Threat of substitutes
3.4.4 Threat of new entrants
3.4.5 Competitive rivalry
4 Pharmacogenomics (PGx) Market, By Ecosystem Players
4.1 Service Providers
4.1.1 Service Providers Market Forecast to 2025 (US$ MN)
4.2 Pharmaceuticals Companies
4.2.1 Pharmaceuticals Companies Market Forecast to 2025 (US$ MN)
4.3 Diagnostic Test Companies
4.3.1 Diagnostic Test Companies Market Forecast to 2025 (US$ MN)
5 Pharmacogenomics (PGx) Market, By Technology
5.1 Polymerase Chain Reaction (PCR)
5.1.1 Polymerase Chain Reaction (PCR) Market Forecast to 2025 (US$ MN)
5.2 Microarray
5.2.1 Microarray Market Forecast to 2025 (US$ MN)
5.3 Sequencing
5.3.1 Sequencing Market Forecast to 2025 (US$ MN)
5.3.1.1 Pyrosequencing
5.3.1.1.1 Pyrosequencing Market Forecast to 2025 (US$ MN)
5.3.1.2 Next-Generation Sequencing (NGS)
5.3.1.2.1 Next-Generation Sequencing (NGS) Market Forecast to 2025 (US$ MN)
5.3.1.3 Sanger Sequencing
5.3.1.3.1 Sanger Sequencing Market Forecast to 2025 (US$ MN)
5.4 Other Technologies
5.4.1 Other Technologies Market Forecast to 2025 (US$ MN)
5.4.1.1 Electrophoresis Market Forecast to 2025 (US$ MN)
5.4.1.1.1 Electrophoresis
5.4.1.2 Mass Spectrometry
5.4.1.2.1 Mass Spectrometry Market Forecast to 2025 (US$ MN)
6 Pharmacogenomics (PGx) Market, By Therapeutic Applications
6.1 Cardiovascular Diseases (CVD)
6.1.1 Cardiovascular Diseases (CVD) Market Forecast to 2025 (US$ MN)
6.2 Central Nervous System (CNS)
6.2.1 Central Nervous System (CNS) Market Forecast to 2025 (US$ MN)
6.3 Cancer/Oncology
6.3.1 Cancer/Oncology Market Forecast to 2025 (US$ MN)
6.4 Infectious Diseases
6.4.1 Infectious Diseases Market Forecast to 2025 (US$ MN)
6.5 Other Diseases
6.5.1 Other Diseases Market Forecast to 2025 (US$ MN)
7 Pharmacogenomics (PGx) Market, By Geography
7.1 North America
7.1.1 North America Market Forecast by Countries to 2025 (US$ MN)
7.1.1.1 US
7.1.1.2 Canada
7.1.1.3 Mexico
7.2 Europe
7.2.1 Europe Market Forecast by Countries to 2025 (US$ MN)
7.2.1.1 France
7.2.1.2 Germany
7.2.1.3 Italy
7.2.1.4 Spain
7.2.1.5 U.K.
7.2.1.6 Rest of Europe
7.3 Asia Pacific
7.3.1 Asia Pacific Market Forecast by Countries to 2025 (US$ MN)
7.3.1.1 Japan
7.3.1.2 China
7.3.1.3 India
7.3.1.4 Australia
7.3.1.5 New Zealand
7.3.1.6 Rest of APAC
7.4 Middle East
7.4.1 Middle East Market Forecast by Countries to 2025 (US$ MN)
7.4.1.1 Saudi Arabia
7.4.1.2 UAE
7.4.1.3 Rest of Middle East
7.5 Latin America
7.5.1 Latin America Market Forecast by Countries to 2025 (US$ MN)
7.5.1.1 Argentina
7.5.1.2 Brazil
7.5.1.3 Rest of Latin America
7.6 Rest of the World (RoW)
7.6.1 RoW Market Forecast by Countries to 2025 (US$ MN)
7.6.1.1 Africa
7.6.1.2 Caribbean
8Key Player Activities
8.1 Mergers & Acquisitions
8.2 Partnerships, Joint Venture’s, Collaborations and Agreements
8.3 Product Launch & Expansions
8.4 Other Activities
9 Leading Companies
9.1 Illumina, Inc.
9.2 Roche Holding Ag-Br
9.3 Myriad Genetics, Inc.
9.4 Abbott Laboratories
9.5 Qiagen, Inc.
9.6 Thermo Fisher Scientific
9.7 Assurex Health, Inc
9.8 Transgenomic, Inc.
9.9 Pfizer, Inc
9.10 Pathway Genomics
9.11 Astrazeneca
9.12 GeneDX
9.13 Affymetrix, Inc.
9.14 Teva Pharmaceutical Industries Ltd.
9.15 Laboratory Corporation of America Holdings
List of Tables
Table 1 Global Pharmacogenomics (PGx) Market By Region, Market Forecast (2013-2025) (US $MN)
Table 2 Global Pharmacogenomics (PGx) Market By Ecosystem Players, Market Forecast (2013-2025) (US $MN)
Table 3 Global Pharmacogenomics (PGx) Market By Service Providers, Market Forecast (2013-2025) (US $MN)
Table 4 Global Pharmacogenomics (PGx) Market By Pharmaceuticals Companies, Market Forecast (2013-2025) (US $MN)
Table 5 Global Pharmacogenomics (PGx) Market By Diagnostic Test Companies, Market Forecast (2013-2025) (US $MN)
Table 6 Global Pharmacogenomics (PGx) Market By Polymerase Chain Reaction (PCR), Market Forecast (2013-2025) (US $MN)
Table 7 Global Pharmacogenomics (PGx) Market By Microarray, Market Forecast (2013-2025) (US $MN)
Table 8 Global Pharmacogenomics (PGx) Market By Sequencing, Market Forecast (2013-2025) (US $MN)
Table 9 Global Pharmacogenomics (PGx) Market By Pyrosequencing, Market Forecast (2013-2025) (US $MN)
Table 10 Global Pharmacogenomics (PGx) Market By Next-Gen Sequencing (NGS), Market Forecast (2013-2025) (US $MN)
Table 11 Global Pharmacogenomics (PGx) Market By Sanger Sequencing, Market Forecast (2013-2025) (US $MN)
Table 12 Global Pharmacogenomics (PGx) Market By Other Technologies, Market Forecast (2013-2025) (US $MN)
Table 13 Global Pharmacogenomics (PGx) Market By Electrophoresis Market Forecast to 2025 (US$ MN), Market Forecast (2013-2025) (US $MN)
Table 14 Global Pharmacogenomics (PGx) Market By Mass Spectrometry, Market Forecast (2013-2025) (US $MN)
Table 15 Global Pharmacogenomics (PGx) Market By Therapeutic Applications, Market Forecast (2013-2025) (US $MN)
Table 16 Global Pharmacogenomics (PGx) Market By Cardiovascular Diseases (CVD), Market Forecast (2013-2025) (US $MN)
Table 17 Global Pharmacogenomics (PGx) Market By Central Nervous System (CNS), Market Forecast (2013-2025) (US $MN)
Table 18 Global Pharmacogenomics (PGx) Market By Cancer/Oncology, Market Forecast (2013-2025) (US $MN)
Table 19 Global Pharmacogenomics (PGx) Market By Infectious Diseases, Market Forecast (2013-2025) (US $MN)
Table 20 Global Pharmacogenomics (PGx) Market By Other Diseases, Market Forecast (2013-2025) (US $MN)
Table 21 North America Pharmacogenomics (PGx) Market By Country, Market Forecast (2013-2025) (US $MN)
Table 22 North America Pharmacogenomics (PGx) Market By Ecosystem Players, Market Forecast (2013-2025) (US $MN)
Table 23 North America Pharmacogenomics (PGx) Market By Service Providers, Market Forecast (2013-2025) (US $MN)
Table 24 North America Pharmacogenomics (PGx) Market By Pharmaceuticals Companies, Market Forecast (2013-2025) (US $MN)
Table 25 North America Pharmacogenomics (PGx) Market By Diagnostic Test Companies, Market Forecast (2013-2025) (US $MN)
Table 26 North America Pharmacogenomics (PGx) Market By Polymerase Chain Reaction (PCR), Market Forecast (2013-2025) (US $MN)
Table 27 North America Pharmacogenomics (PGx) Market By Microarray, Market Forecast (2013-2025) (US $MN)
Table 28 North America Pharmacogenomics (PGx) Market By Sequencing, Market Forecast (2013-2025) (US $MN)
Table 29 North America Pharmacogenomics (PGx) Market By Pyrosequencing, Market Forecast (2013-2025) (US $MN)
Table 30 North America Pharmacogenomics (PGx) Market By Next-Generation Sequencing (NGS), Market Forecast (2013-2025) (US $MN)
Table 31 North America Pharmacogenomics (PGx) Market By Sanger Sequencing, Market Forecast (2013-2025) (US $MN)
Table 32 North America Pharmacogenomics (PGx) Market By Other Technologies, Market Forecast (2013-2025) (US $MN)
Table 33 North America Pharmacogenomics (PGx) Market By Electrophoresis Market Forecast to 2025 (US$ MN), Market Forecast (2013-2025) (US $MN)
Table 34 North America Pharmacogenomics (PGx) Market By Mass Spectrometry, Market Forecast (2013-2025) (US $MN)
Table 35 North America Pharmacogenomics (PGx) Market By Therapeutic Applications, Market Forecast (2013-2025) (US $MN)
Table 36 North America Pharmacogenomics (PGx) Market By Cardiovascular Diseases (CVD), Market Forecast (2013-2025) (US $MN)
Table 37 North America Pharmacogenomics (PGx) Market By Central Nervous System (CNS), Market Forecast (2013-2025) (US $MN)
Table 38 North America Pharmacogenomics (PGx) Market By Cancer/Oncology, Market Forecast (2013-2025) (US $MN)
Table 39 North America Pharmacogenomics (PGx) Market By Infectious Diseases, Market Forecast (2013-2025) (US $MN)
Table 40 North America Pharmacogenomics (PGx) Market By Other Diseases, Market Forecast (2013-2025) (US $MN)
Table 41 Europe Pharmacogenomics (PGx) Market By Country, Market Forecast (2013-2025) (US $MN)
Table 42 Europe Pharmacogenomics (PGx) Market By Ecosystem Players, Market Forecast (2013-2025) (US $MN)
Table 43 Europe Pharmacogenomics (PGx) Market By Service Providers, Market Forecast (2013-2025) (US $MN)
Table 44 Europe Pharmacogenomics (PGx) Market By Pharmaceuticals Companies, Market Forecast (2013-2025) (US $MN)
Table 45 Europe Pharmacogenomics (PGx) Market By Diagnostic Test Companies, Market Forecast (2013-2025) (US $MN)
Table 46 Europe Pharmacogenomics (PGx) Market By Polymerase Chain Reaction (PCR), Market Forecast (2013-2025) (US $MN)
Table 47 Europe Pharmacogenomics (PGx) Market By Microarray, Market Forecast (2013-2025) (US $MN)
Table 48 Europe Pharmacogenomics (PGx) Market By Sequencing, Market Forecast (2013-2025) (US $MN)
Table 49 Europe Pharmacogenomics (PGx) Market By Pyrosequencing, Market Forecast (2013-2025) (US $MN)
Table 50 Europe Pharmacogenomics (PGx) Market By Next-Generation Sequencing (NGS), Market Forecast (2013-2025) (US $MN)
Table 51 Europe Pharmacogenomics (PGx) Market By Sanger Sequencing, Market Forecast (2013-2025) (US $MN)
Table 52 Europe Pharmacogenomics (PGx) Market By Other Technologies, Market Forecast (2013-2025) (US $MN)
Table 53 Europe Pharmacogenomics (PGx) Market By Electrophoresis Market Forecast to 2025 (US$ MN), Market Forecast (2013-2025) (US $MN)
Table 54 Europe Pharmacogenomics (PGx) Market By Mass Spectrometry, Market Forecast (2013-2025) (US $MN)
Table 55 Europe Pharmacogenomics (PGx) Market By Therapeutic Applications, Market Forecast (2013-2025) (US $MN)
Table 56 Europe Pharmacogenomics (PGx) Market By Cardiovascular Diseases (CVD), Market Forecast (2013-2025) (US $MN)
Table 57 Europe Pharmacogenomics (PGx) Market By Central Nervous System (CNS), Market Forecast (2013-2025) (US $MN)
Table 58 Europe Pharmacogenomics (PGx) Market By Cancer/Oncology, Market Forecast (2013-2025) (US $MN)
Table 59 Europe Pharmacogenomics (PGx) Market By Infectious Diseases, Market Forecast (2013-2025) (US $MN)
Table 60 Europe Pharmacogenomics (PGx) Market By Other Diseases, Market Forecast (2013-2025) (US $MN)
Table 61 Asia Pacific Pharmacogenomics (PGx) Market By Country, Market Forecast (2013-2025) (US $MN)
Table 62 Asia Pacific Pharmacogenomics (PGx) Market By Ecosystem Players, Market Forecast (2013-2025) (US $MN)
Table 63 Asia Pacific Pharmacogenomics (PGx) Market By Service Providers, Market Forecast (2013-2025) (US $MN)
Table 64 Asia Pacific Pharmacogenomics (PGx) Market By Pharmaceuticals Companies, Market Forecast (2013-2025) (US $MN)
Table 65 Asia Pacific Pharmacogenomics (PGx) Market By Diagnostic Test Companies, Market Forecast (2013-2025) (US $MN)
Table 66 Asia Pacific Pharmacogenomics (PGx) Market By Polymerase Chain Reaction (PCR), Market Forecast (2013-2025) (US $MN)
Table 67 Asia Pacific Pharmacogenomics (PGx) Market By Microarray, Market Forecast (2013-2025) (US $MN)
Table 68 Asia Pacific Pharmacogenomics (PGx) Market By Sequencing, Market Forecast (2013-2025) (US $MN)
Table 69 Asia Pacific Pharmacogenomics (PGx) Market By Pyrosequencing, Market Forecast (2013-2025) (US $MN)
Table 70 Asia Pacific Pharmacogenomics (PGx) Market By Next-Generation Sequencing (NGS), Market Forecast (2013-2025) (US $MN)
Table 71 Asia Pacific Pharmacogenomics (PGx) Market By Sanger Sequencing, Market Forecast (2013-2025) (US $MN)
Table 72 Asia Pacific Pharmacogenomics (PGx) Market By Other Technologies, Market Forecast (2013-2025) (US $MN)
Table 73 Asia Pacific Pharmacogenomics (PGx) Market By Electrophoresis Market Forecast to 2025 (US$ MN), Market Forecast (2013-2025) (US $MN)
Table 74 Asia Pacific Pharmacogenomics (PGx) Market By Mass Spectrometry, Market Forecast (2013-2025) (US $MN)
Table 75 Asia Pacific Pharmacogenomics (PGx) Market By Therapeutic Applications, Market Forecast (2013-2025) (US $MN)
Table 76 Asia Pacific Pharmacogenomics (PGx) Market By Cardiovascular Diseases (CVD), Market Forecast (2013-2025) (US $MN)
Table 77 Asia Pacific Pharmacogenomics (PGx) Market By Central Nervous System (CNS), Market Forecast (2013-2025) (US $MN)
Table 78 Asia Pacific Pharmacogenomics (PGx) Market By Cancer/Oncology, Market Forecast (2013-2025) (US $MN)
Table 79 Asia Pacific Pharmacogenomics (PGx) Market By Infectious Diseases, Market Forecast (2013-2025) (US $MN)
Table 80 Asia Pacific Pharmacogenomics (PGx) Market By Other Diseases, Market Forecast (2013-2025) (US $MN)
Table 81 Middle East Pharmacogenomics (PGx) Market By Country, Market Forecast (2013-2025) (US $MN)
Table 82 Middle East Pharmacogenomics (PGx) Market By Ecosystem Players, Market Forecast (2013-2025) (US $MN)
Table 83 Middle East Pharmacogenomics (PGx) Market By Service Providers, Market Forecast (2013-2025) (US $MN)
Table 84 Middle East Pharmacogenomics (PGx) Market By Pharmaceuticals Companies, Market Forecast (2013-2025) (US $MN)
Table 85 Middle East Pharmacogenomics (PGx) Market By Diagnostic Test Companies, Market Forecast (2013-2025) (US $MN)
Table 86 Middle East Pharmacogenomics (PGx) Market By Polymerase Chain Reaction (PCR), Market Forecast (2013-2025) (US $MN)
Table 87 Middle East Pharmacogenomics (PGx) Market By Microarray, Market Forecast (2013-2025) (US $MN)
Table 88 Middle East Pharmacogenomics (PGx) Market By Sequencing, Market Forecast (2013-2025) (US $MN)
Table 89 Middle East Pharmacogenomics (PGx) Market By Pyrosequencing, Market Forecast (2013-2025) (US $MN)
Table 90 Middle East Pharmacogenomics (PGx) Market By Next-Generation Sequencing (NGS), Market Forecast (2013-2025) (US $MN)
Table 91 Middle East Pharmacogenomics (PGx) Market By Sanger Sequencing, Market Forecast (2013-2025) (US $MN)
Table 92 Middle East Pharmacogenomics (PGx) Market By Other Technologies, Market Forecast (2013-2025) (US $MN)
Table 93 Middle East Pharmacogenomics (PGx) Market By Electrophoresis Market Forecast to 2025 (US$ MN), Market Forecast (2013-2025) (US $MN)
Table 94 Middle East Pharmacogenomics (PGx) Market By Mass Spectrometry, Market Forecast (2013-2025) (US $MN)
Table 95 Middle East Pharmacogenomics (PGx) Market By Therapeutic Applications, Market Forecast (2013-2025) (US $MN)
Table 96 Middle East Pharmacogenomics (PGx) Market By Cardiovascular Diseases (CVD), Market Forecast (2013-2025) (US $MN)
Table 97 Middle East Pharmacogenomics (PGx) Market By Central Nervous System (CNS), Market Forecast (2013-2025) (US $MN)
Table 98 Middle East Pharmacogenomics (PGx) Market By Cancer/Oncology, Market Forecast (2013-2025) (US $MN)
Table 99 Middle East Pharmacogenomics (PGx) Market By Infectious Diseases, Market Forecast (2013-2025) (US $MN)
Table 100 Middle East Pharmacogenomics (PGx) Market By Other Diseases, Market Forecast (2013-2025) (US $MN)
Table 101 Latin America Pharmacogenomics (PGx) Market By Country, Market Forecast (2013-2025) (US $MN)
Table 102 Latin America Pharmacogenomics (PGx) Market By Ecosystem Players, Market Forecast (2013-2025) (US $MN)
Table 103 Latin America Pharmacogenomics (PGx) Market By Service Providers, Market Forecast (2013-2025) (US $MN)
Table 104 Latin America Pharmacogenomics (PGx) Market By Pharmaceuticals Companies, Market Forecast (2013-2025) (US $MN)
Table 105 Latin America Pharmacogenomics (PGx) Market By Diagnostic Test Companies, Market Forecast (2013-2025) (US $MN)
Table 106 Latin America Pharmacogenomics (PGx) Market By Polymerase Chain Reaction (PCR), Market Forecast (2013-2025) (US $MN)
Table 107 Latin America Pharmacogenomics (PGx) Market By Microarray, Market Forecast (2013-2025) (US $MN)
Table 108 Latin America Pharmacogenomics (PGx) Market By Sequencing, Market Forecast (2013-2025) (US $MN)
Table 109 Latin America Pharmacogenomics (PGx) Market By Pyrosequencing, Market Forecast (2013-2025) (US $MN)
Table 110 Latin America Pharmacogenomics (PGx) Market By Next-Generation Sequencing (NGS), Market Forecast (2013-2025) (US $MN)
Table 111 Latin America Pharmacogenomics (PGx) Market By Sanger Sequencing, Market Forecast (2013-2025) (US $MN)
Table 112 Latin America Pharmacogenomics (PGx) Market By Other Technologies, Market Forecast (2013-2025) (US $MN)
Table 113 Latin America Pharmacogenomics (PGx) Market By Electrophoresis Market Forecast to 2025 (US$ MN), Market Forecast (2013-2025) (US $MN)
Table 114 Latin America Pharmacogenomics (PGx) Market By Mass Spectrometry, Market Forecast (2013-2025) (US $MN)
Table 115 Latin America Pharmacogenomics (PGx) Market By Therapeutic Applications, Market Forecast (2013-2025) (US $MN)
Table 116 Latin America Pharmacogenomics (PGx) Market By Cardiovascular Diseases (CVD), Market Forecast (2013-2025) (US $MN)
Table 117 Latin America Pharmacogenomics (PGx) Market By Central Nervous System (CNS), Market Forecast (2013-2025) (US $MN)
Table 118 Latin America Pharmacogenomics (PGx) Market By Cancer/Oncology, Market Forecast (2013-2025) (US $MN)
Table 119 Latin America Pharmacogenomics (PGx) Market By Infectious Diseases, Market Forecast (2013-2025) (US $MN)
Table 120 Latin America Pharmacogenomics (PGx) Market By Other Diseases, Market Forecast (2013-2025) (US $MN)
Table 121 RoW Pharmacogenomics (PGx) Market By Country, Market Forecast (2013-2025) (US $MN)
Table 122 RoW Pharmacogenomics (PGx) Market By Ecosystem Players, Market Forecast (2013-2025) (US $MN)
Table 123 RoW Pharmacogenomics (PGx) Market By Service Providers, Market Forecast (2013-2025) (US $MN)
Table 124 RoW Pharmacogenomics (PGx) Market By Pharmaceuticals Companies, Market Forecast (2013-2025) (US $MN)
Table 125 RoW Pharmacogenomics (PGx) Market By Diagnostic Test Companies, Market Forecast (2013-2025) (US $MN)
Table 126 RoW Pharmacogenomics (PGx) Market By Polymerase Chain Reaction (PCR), Market Forecast (2013-2025) (US $MN)
Table 127 RoW Pharmacogenomics (PGx) Market By Microarray, Market Forecast (2013-2025) (US $MN)
Table 128 RoW Pharmacogenomics (PGx) Market By Sequencing, Market Forecast (2013-2025) (US $MN)
Table 129 RoW Pharmacogenomics (PGx) Market By Pyrosequencing, Market Forecast (2013-2025) (US $MN)
Table 130 RoW Pharmacogenomics (PGx) Market By Next-Generation Sequencing (NGS), Market Forecast (2013-2025) (US $MN)
Table 131 RoW Pharmacogenomics (PGx) Market By Sanger Sequencing, Market Forecast (2013-2025) (US $MN)
Table 132 RoW Pharmacogenomics (PGx) Market By Other Technologies, Market Forecast (2013-2025) (US $MN)
Table 133 RoW Pharmacogenomics (PGx) Market By Electrophoresis Market Forecast to 2025 (US$ MN), Market Forecast (2013-2025) (US $MN)
Table 134 RoW Pharmacogenomics (PGx) Market By Mass Spectrometry, Market Forecast (2013-2025) (US $MN)
Table 135 RoW Pharmacogenomics (PGx) Market By Therapeutic Applications, Market Forecast (2013-2025) (US $MN)
Table 136 RoW Pharmacogenomics (PGx) Market By Cardiovascular Diseases (CVD), Market Forecast (2013-2025) (US $MN)
Table 137 RoW Pharmacogenomics (PGx) Market By Central Nervous System (CNS), Market Forecast (2013-2025) (US $MN)
Table 138 RoW Pharmacogenomics (PGx) Market By Cancer/Oncology, Market Forecast (2013-2025) (US $MN)
Table 139 RoW Pharmacogenomics (PGx) Market By Infectious Diseases, Market Forecast (2013-2025) (US $MN)
Table 140 RoW Pharmacogenomics (PGx) Market By Other Diseases, Market Forecast (2013-2025) (US $MN)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report